Among adult patients with #MOGAD, discontinuation of oral immunosuppressants or rituximab was associated with a low 1-year relapse risk, especially after ≥1 year of treatment and ≥2 years since last relapse.
ja.ma/4rVtr6u
2
8
331
Search
1
4
134
"Disease...attacks (for #NMOSD & #MOGAD) can occur during #pregnancy, are common postpartum, & can cause preventable, long-term maternal disability. We offer expert recommendations for therapy choice, #infant vaccinations, & fetal & infant monitoring...." doi.org/10.1016/S1474-…
2
62
Among adult patients with #MOGAD, discontinuation of oral immunosuppressants or rituximab was associated with a low 1-year relapse risk, especially after ≥1 year of treatment and ≥2 years since last relapse.
ja.ma/41pIOZN
10
23
1.8K
3
9
459
"...#EBNA1 positivity in [#MultipleSclerosis] ranged from about 92% to 93% depending on the age group. In #MOGAD, it was around 61%. In #NMOSD, about 89%. In other neurological diseases, rates were in the 70% to 80% range, and in controls, about 78%."
🧬 Could #EBV antibodies help clarify #MS diagnoses?
Tanuja Chitnis, MD discusses research showing EBNA-1 antibodies are present in ~98–99% of patients with MS
Read more here:hubs.li/Q047kNWq0E
#MultipleSclerosis #Neurology #EpsteinBarrVirus #Q&A
NeuroVoices: Tanuja Chitnis, MD, on EBNA-1 Antibodies to Distinguish MS, MOGAD, and NMOSD |...
The division chief of neuroimmunology at Brigham and Women’s Hospital discusses longitudinal EBNA-1 antibody data and its potential role as a complementary biomarker to distinguish MS from related...
From neurologylive.com 2
219
1
29
436
Level up! Who’s ready for #MOGAD awareness month coming up this April? 🥶🧠👁️🧬🔬⚗️🔭🥼🧑🏻🔬👩🏻🔬👨🔬
Meeeeeeeeee 33.3%
I’m ready, I’m ready 50.0%
MEEEEEEE 16.7%
6 votes · Final results
2
257
🌺On February 21st, we hosted a Patient Day in Honolulu for #MG, #MOGAD and #NMOSD in collaboration with Dr. Natalia Gonzalez Caldito and Dr. Alexandra Galati.
Click here to read the event recap and view our photo gallery:lnkd.in/dzimqQgFqU
3
158
Presenting our MOG cohort from the Neuroimmunology UC team, highlighting real-world clinical data in MOGAD. #NeuroinmunoUC #MOGAD @TheMOGProject @SOCHEDEM1 @lactrims_org @EthelScl @adelcanto
4
11
369
Krissy Dilger of @wearesrna interviewed Dr. Vivien Xie regarding her research on the significance of #brain lesions in pediatric MOG antibody disease (#MOGAD). Listen to the podcast episode here: srna.ngo/rb2
ABCs of MOGAD - Significance of Brain Lesions in Pediatric MOGAD
Dr. Vivien Xie discussed the significance of brain lesions in pediatric MOG antibody disease (MOGAD) and the results of her recent study.
From wearesrna.org 2
184
The Sumaira Foundation is proud to support the XIII @lactrims_org Congress in Mexico City! 🇲🇽 From March 18–21, experts from across Latin America will come together to share the latest on #MS, #NMOSD and #MOGAD.
Click here to learn more and registerlactrims2026.lactrimsweb.orgN4m
5
72
Dr. Eoin Flanagan from the Mayo Clinic recently joined @wearesrna as a guest speaker on their "ABCs of #MOGAD" podcast to talk about #steroid dependence and MOG antibody disease. Listen here: srna.ngo/eka.
ABCs of MOGAD – Steroid Dependence
Dr. Eoin Flanagan from the Mayo Clinic discussed MOG antibody disease, the risks of steroid dependence, and common solutions.
From wearesrna.org 1
186
取り敢えず
#除外診断 の候補として
上がった病名が‥
Dr.曰く
#視神経脊髄炎
#MOGAD （MOG抗体関連疾患）
#SLE
#シェーグレン症候群
#Susac症候群
#NeuroSweet病
#脳梗塞
やれやれ
やり直しですわぁ〜
2
3
201
🔝🟢High EBNA1 peptide antibody titers, especially when present in >1 longitudinal samples, show excellent sensitivity and specificity for distinguishing #MultipleSclerosis from other autoimmune (e.g #MOGAD) and non-autoimmune neurologic diseases, even outperforming OCB!�aYcU
1
11
27
1.7K